| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.23 | 3e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.23 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.081 | 0.1 |